Paula Pohlmann
Overview
Explore the profile of Paula Pohlmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
178
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Tozbikian G, Krishnamurthy S, Bui M, Feldman M, Hicks D, Jaffer S, et al.
Arch Pathol Lab Med
. 2023 Apr;
148(2):242-255.
PMID: 37014972
Context.—: Human epidermal growth factor receptor 2 (HER2) status in breast cancer is currently classified as negative or positive for selecting patients for anti-HER2 targeted therapy. The evolution of the...
12.
Wolf D, Yau C, Wulfkuhle J, Brown-Swigart L, Gallagher R, Lee P, et al.
Cancer Cell
. 2022 May;
40(6):609-623.e6.
PMID: 35623341
Using pre-treatment gene expression, protein/phosphoprotein, and clinical data from the I-SPY2 neoadjuvant platform trial (NCT01042379), we create alternative breast cancer subtypes incorporating tumor biology beyond clinical hormone receptor (HR) and...
13.
Lynce F, Saleh M, Shajahan-Haq A, Gallagher C, Dilawari A, Hahn O, et al.
Contemp Clin Trials Commun
. 2018 Jul;
10:190-192.
PMID: 30009277
Palbociclib has been shown to be a highly effective therapy in hormone receptor positive metastatic breast cancer when used in combination with letrozole or fulvestrant. Grade 3/4 neutropenia is a...
14.
Mahajan A, Sugita B, Duttargi A, Saenz F, Krawczyk E, McCutcheon J, et al.
PLoS One
. 2017 Oct;
12(10):e0186190.
PMID: 29049316
Conditionally reprogrammed cells (CRCs) are epithelial cells that are directly isolated from patients' specimens and propagated in vitro with feeder cells and a Rho kinase inhibitor. A number of these...
15.
Caleffi M, Ribeiro R, Duarte Filho D, Ashton-Prolla P, Bedin Jr A, Skonieski G, et al.
BMC Public Health
. 2009 Mar;
9:83.
PMID: 19284670
Background: Breast cancer (BC) is a major public health problem, with rising incidence in many regions of the globe. Although mortality has recently dropped in developed countries, death rates are...
16.
Pohlmann P, DiLeone L, Cancella A, Caldas A, Dal Lago L, Campos Jr O, et al.
Am J Clin Oncol
. 2002 Oct;
25(5):496-501.
PMID: 12393992
On the basis of the demonstrated single-agent activity of cisplatin in patients with advanced cervical cancer and the observation of in vitro synergism between this agent and decitabine, a new...